Motilal Oswal BSE Healthcare ETF - Growth - Regular Plan

  • Previous Nav

  • Net Change on 08-10-2025

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI Nifty 50 ETF Sep 01, 2015 2.49 14.42 17.75 0.05 63,831.92
UTI BSE Sensex ETF Sep 01, 2015 2.25 13.40 16.80 0.05 49,897.45
UTI Nifty Bank ETF Sep 03, 2020 12.18 13.64 20.35 0.17 3,539.81
UTI Nifty Next 50 Exchange Traded Fund Aug 04, 2017 -4.86 17.94 21.04 0.15 2,023.43
Motilal Oswal Nifty Midcap 100 ETF Jan 31, 2011 2.17 23.48 28.39 0.22 674.35

Fund Holdings as on 30-September-2025

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Max Healthcare Institute Limited

  • Apollo Hospitals Enterprise Limited

  • Dr. Reddy's Laboratories Limited

  • Divi's Laboratories Limited

  • Fortis Healthcare Limited

  • Lupin Limited

  • Torrent Pharmaceuticals Limited

  • Laurus Labs Limited

  • Alkem Laboratories Limited

  • Aurobindo Pharma Limited

  • Glenmark Pharmaceuticals Limited

  • Mankind Pharma Limited

  • Zydus Lifesciences Limited

  • Biocon Limited

  • IPCA Laboratories Limited

  • Krishna Institute Of Medical Sciences Limited

  • Gland Pharma Limited

  • Abbott India Limited

  • Aster DM Healthcare Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Neuland Laboratories Limited

  • Wockhardt Limited

  • Syngene International Limited

  • Dr. Lal Path Labs Limited

  • Narayana Hrudayalaya Limited

  • Piramal Pharma Limited

  • Cohance Lifesciences Limited

  • Global Health Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Ajanta Pharma Limited

  • Onesource Specialty Pharma Limited

  • Jubilant Pharmova Limited

  • Sai Life Sciences Limited

  • Pfizer Limited

  • Granules India Limited

  • Poly Medicure Limited

  • Natco Pharma Limited

  • Acutaas Chemicals Limited

  • Rainbow Childrens Medicare Limited

  • Eris Lifesciences Limited

  • AstraZeneca Pharma India Limited

  • Jupiter Life Line Hospitals Limited

  • Indegene Limited

  • Concord Biotech Limited

  • Strides Pharma Science Limited

  • Metropolis Healthcare Limited

  • Procter & Gamble Health Limited

  • Alembic Pharmaceuticals Limited

  • Vijaya Diagnostic Centre Limited

  • Aarti Pharmalabs Limited

  • Sanofi India Limited

  • Shilpa Medicare Limited

  • Caplin Point Laboratories Limited

  • Dr Agarwals Health Care Limited

  • Marksans Pharma Limited

  • Healthcare Global Enterprises Limited

  • Sanofi Consumer Healthcare India Limited

  • Emcure Pharmaceuticals Limited

  • Alivus Life Sciences Limited

  • Kovai Medical Center and Hospital Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Sequent Scientific Limited

  • FDC Limited

  • Net Receivables / (Payables)

  • Indraprastha Medical Corporation Limited

  • Supriya Lifescience Limited

  • Senores Pharmaceuticals Limited

  • Thyrocare Technologies Limited

  • Dishman Carbogen Amcis Limited

  • Solara Active Pharma Sciences Limited

  • Aarti Drugs Limited

  • Morepen Laboratories Limited

  • Blue Jet Healthcare Ltd

  • Advanced Enzyme Technologies Limited

  • Krsnaa Diagnostics Limited

  • Innova Captab Limited

  • Gujarat Themis Biosyn Limited

  • Sun Pharma Advanced Research Company Limited

  • Suven Life Sciences Limited

  • Akums Drugs and Pharmaceuticals Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Fischer Medical Ventures Limited

  • Indoco Remedies Limited

  • Orchid Pharma Limited

  • Vimta Labs Limited

  • Bliss GVS Pharma Limited

  • Gufic Biosciences Limited

  • RPG Life Sciences Limited

  • Unichem Laboratories Limited

  • Hikal Limited

  • Syncom Formulations India Limited

  • Windlas Biotech Limited

  • Hester Biosciences Limited

  • SMS Pharmaceuticals Limited

  • Shalby Limited

  • Sigachi Industries Limited

  • 3B BlackBio Dx Limited

  • Artemis Medicare Services Limited

  • Panacea Biotec Limited

  • Suraksha Diagnostic Limited

  • Dr.Agarwals Eye Hospital Limited

  • Novartis India Limited

  • Laxmi Dental Limited

  • Lincoln Pharmaceuticals Limited

  • Wanbury Limited

  • Kopran Limited

  • Tarsons Products Limited

  • Bajaj Healthcare Limited

  • Jagsonpal Pharmaceuticals Limited

  • Kwality Pharmaceuticals Limited

  • GPT Healthcare Limited

  • Themis Medicare Limited

  • Fermenta Biotech Limited

  • KMC Speciality Hospitals (India) Limited

  • Sastasundar Ventures Limited

  • Anuh Pharma Limited

  • Nectar Lifesciences Limited

  • Shree Ganesh Remedies Limited

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Chemicals

  • Pesticides & Agrochemicals

  • Plastic Products

  • Trading

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal BSE Healthcare ETF

Scheme Analysis

Motilal Oswal BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹32.76 crore. Motilal Oswal BSE Healthcare ETF is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of Motilal Oswal BSE Healthcare ETF ended down ₹-0.18(-0.4%)yesterday to ₹44.4029.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022 40548002
amc@motilaloswal.com
022-22816161